ThomasHenryWaidMD

PubMed

• 30 citations
  The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era.
  Volker Nickeleit, Harsharan K. Singh, Darshana Dadhania, Virgilius Cornea, Amr El-Husseini, Ana Lia Castellanos, Vicki G. Davis, Thomas Waid, Surya V. Seshan> ;American Journal of Transplantation. 2021 Feb 1
• 2 citations
  Impact of human leukocyte antigen and calculated panel reactive antibody on BK viremia in kidney transplant recipients: A single-center experience and literature review
  Amr El-Husseini, Waleed M. Hassan, Maria Yaseen, Belal Suleiman, Sherif Saleh, Omar Malik, Hasan Ashqar, Amita Maibam, Xiaonan Mei, Ana Lia Castellanos, Virgilius Corn...> ;Transplant Infectious Disease. 2019 Aug 1
• 13 citations
  Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation.
  Omar Malik, Sherif Saleh, Belal Suleiman, Bilal Ashqar, Amita Maibam, Maria Yaseen, Amro Elrefaei, Abigail Hines, Virgilius Cornea, Amr El-Husseini, Xiaonan Mei, Rober...> ;Transplantation Proceedings. 2019 Jul 1
• 141 citations
  Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
  Matthew R. Weir, Shamkant Mulgaonkar, L. Chan, H. Shidban, Thomas Waid, Dennis Preston, Roberto N. Kalil, Thomas C. Pearson> ;Kidney International. 2011 Apr 2
• 11 citations
  T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
  Thomas Waid, John S. Thompson, Maria Z. Siemionow, Stephen A. Brown> ;Drug Design, Development and Therapy. 2009 Jun 25
• 35 citations
  Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
  Fuad S. Shihab, Thomas Waid, David J. Conti, Harold Yang, Michael J. Holman, Laura C. Mulloy, Alice K. Henning, John Holman, M. Roy First> ;Transplantation. 2008 May 15
• 16 citations
  Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure
  Thomas Waid, Edward J. Alfrey, Laura C. Mulloy, Faud S. Shihab, David V. Conti, Richard B. Freeman, Angelo M. de Mattos, Stephen C. Jensik, Stanley C. Jordan, G. Franc...> ;Clinical Transplantation. 2005 Oct 1
• 15 citations
  Treatment of Respiratory Syncytial Virus Pneumonia in a Lung Transplant Recipient: Case Report and Review of the Literature
  Jeremy D. Flynn, Wendell S. Akers, Mikael Jones, Natasa Stevkovic, Thomas Waid, Timothy W. Mullett, Salik A. Jahania> ;Pharmacotherapy. 2004 Jul 1
• 16 citations
  Recipient outcome following living donor kidney transplantation using kidneys procured laparoscopically.
  K Sudhakar Reddy, Michael J. Mastrangelo, Thomas D. Johnston, Taqi F. Toufeeq Khan, Thomas Waid, Wade McKeown, Bruce A. Lucas, Dinesh Ranjan> ;Clinical Transplantation. 2003 Jun 10
• 31 citations
  Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation.
  K Sudhakar Reddy, Darcy Davies, Debra B. Ormond, Sony Tuteja, Bruce A. Lucas, Thomas D. Johnston, Thomas Waid, John McKeown, Dinesh Ranjan> ;American Journal of Transplantation. 2003 Apr 1
• 146 citations
  Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure
  K Sudhakar Reddy, Don Stablein, S. Taranto, Robert J. Stratta, Thomas D. Johnston, Thomas Waid, J.Wade McKeown, Bruce A. Lucas, Dinesh Ranjan> ;American Journal of Kidney Diseases. 2003 Feb 1
• 20 citations
  Transplantation of pediatric en bloc cadaver kidneys into adult recipients: a single-center experience.
  Tim Ruff, K Sudhakar Reddy, Thomas D. Johnston, Thomas Waid, Wade McKeown, Taqi F. Toufeeq Khan, Dinesh Ranjan, Bruce A. Lucas> ;The American Surgeon. 2002 Oct 1
• 1 citations
  Pancreas transplantation: current status and experience at the University of Kentucky.
  Kunam S. Reddy, Dinesh Ranjan, Thomas D. Johnston, Taqi F. Toufeeq Khan, Dennis G. Karounos, Thomas Waid, Wade McKeown, Bruce A. Lucas, Robert M. Mentzer> ;The Journal of the Kentucky Medical Association. 2002 Jul 1
• 5 citations
  Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
  Kunam S. Reddy, D Stablein, S. Taranto, Robert J. Stratta, Thomas D. Johnston, Thomas Waid, J. W. Mckeown, Bruce A. Lucas, Dinesh Ranjan> ;Transplantation Proceedings. 2001 Feb 1
• 8 citations
  Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
  Thomas Waid, Thompson Js, J. W. Mckeown, S. A. Brown, Sekela Me> ;The Journal of Heart and Lung Transplantation. 1997 Sep 1
• 21 citations
  Treatment of renal allograft rejection with T10B9.1A31 or OKT3 : Final analysis of a phase II clinical trial
  Thomas Waid, Bruce A. Lucas, John F. Thompson, John McKeown, Stephen P. A. Brown, Richard J. Kryscio, Lisa Skeeters> ;Transplantation. 1997 Jul 27
• 18 citations
  Safety and tolerability of cyclosporine microemulsion versus cyclosporine: Two-year data in primary renal allograft recipients: A report of the Neoral Study Group
  Mark D. Pescovitz, Gary Barone, M. Gerry Choc, Donald E. Hricik, Dar Shong Hwang, Judy Hyun Ju Jin, Jon B. Klein, Christopher L. Marsh, David I. Min, Raymond Pollak, T...> ;Transplantation. 1997 Mar 15
• 3 citations
  T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
  Stephen A. Brown, Bruce A. Lucas, T. Waid, W. McKeown, M. Tsuchida, John F. Thompson> ;Transplantation Proceedings. 1997 Feb 1
• 9 citations
  T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.
  Stephen A. Brown, Bruce A. Lucas, Thomas Waid, J. W. Mckeown, S Barve, L R Jackson, John S. Thompson> ;Clinical Transplantation. 1996 Dec 1
• 5 citations
  Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
  Barone G, Bunke Cm, Choc Mg, Donald E. Hricik, J. H J Jin, Jon B. Klein, C. L. Marsh, D. I. Min, Pescovitz, R. Pollak, Timothy L. Pruett, James B. Stinson, J. S. Thomp...> ;Transplantation Proceedings. 1996 Aug 1
• 32 citations
  The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients
  Gary Barone, C. Martin Bunke, M. Gerry Choc, Donald E. Hricik, Judy Hyun Ju Jin, Jon B. Klein, Christopher L. Marsh, David I. Min, Mark D. Pescovitz, Raymond Pollak, T...> ;Transplantation. 1996 Mar 27
• 82 citations
  The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
  Gary Barone, Cheng Tao Chang, M. Gerry Choc, Jon B. Klein, Christopher L. Marsh, John A. Meligeni, David I. Min, Mark D. Pescovitz, Raymond Pollak, Timothy L. Pruett, ...> ;Transplantation. 1996 Mar 27
• 4 citations
  Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation.
  Waid Th, McKeown Jw> ;Transplantation Proceedings. 1995 Oct 1
• 4 citations
  Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
  Bruce A. Lucas, T. H. Waid, J. S. Thompson, S. A. Brown, L. C. Munch, J. W. Mckeown, R. J. Kryscio, R. J. Prebeck> ;Transplantation Proceedings. 1993 Feb 1
• 40 citations
  Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.
  Thomas Waid, Bruce A. Lucas, John S. Thompson, Stephen P. A. Brown, Larry C. Munch, Rhonda J. Prebeck, Doreen Jezek> ;Transplantation. 1992 Jan 1
• Join now to see all